[HTML][HTML] SARS-CoV-2 and the host cell: a tale of interactions

M Pizzato, C Baraldi, G Boscato Sopetto… - Frontiers in …, 2022 - frontiersin.org
The ability of a virus to spread between individuals, its replication capacity and the clinical
course of the infection are macroscopic consequences of a multifaceted molecular …

[HTML][HTML] The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies

S Zhang, L Wang, G Cheng - Molecular therapy, 2022 - cell.com
The SARS-CoV-2 virus, the pathogen causing COVID-19, has caused more than 200 million
confirmed cases, resulting in more than 4.5 million deaths worldwide by the end of August …

[HTML][HTML] Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing

K Chathuranga, A Weerawardhana… - … & Molecular Medicine, 2021 - nature.com
A harmonized balance between positive and negative regulation of pattern recognition
receptor (PRR)-initiated immune responses is required to achieve the most favorable …

[HTML][HTML] SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1

SY Fung, KL Siu, H Lin, CP Chan, ML Yeung, DY Jin - Cell & bioscience, 2022 - Springer
Background SARS-CoV-2 is the causative agent of COVID-19. Overproduction and release
of proinflammatory cytokines are the underlying cause of severe COVID-19. Treatment of …

[HTML][HTML] Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: A comprehensive evidential insight

C Bhowal, S Ghosh, D Ghatak, R De - Molecular and cellular biochemistry, 2023 - Springer
SARS-CoV-2 is a positive-strand RNA virus that infects humans through the nasopharyngeal
and oral route causing COVID-19. Scientists left no stone unturned to explore a targetable …

[HTML][HTML] Immune evasion of SARS-CoV-2 from interferon antiviral system

YQ Min, M Huang, X Sun, F Deng, H Wang… - Computational and …, 2021 - Elsevier
The on-going pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to unprecedented medical and …

A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites

MJ Islam, NN Islam, MS Alom, M Kabir, MA Halim - Immunobiology, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
COVID-19, is a highly transmittable and pathogenic human coronavirus that first emerged in …

[HTML][HTML] SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways

SJ Oh, OS Shin - Journal of Microbiology, 2022 - Springer
With global expansion of the COVID-19 pandemic and the emergence of new variants,
extensive efforts have been made to develop highly effective antiviral drugs and vaccines …

[HTML][HTML] Biochemical analysis of SARS-CoV-2 Nsp13 helicase implicated in COVID-19 and factors that regulate its catalytic functions

JA Sommers, LN Loftus, MP Jones, RA Lee… - Journal of Biological …, 2023 - ASBMB
Replication of the 30-kilobase genome of SARS-CoV-2, responsible for COVID-19, is a key
step in the coronavirus life cycle that requires a set of virally encoded nonstructural proteins …

The deubiquitinase USP29 promotes SARS-CoV-2 virulence by preventing proteasome degradation of ORF9b

W Gao, L Wang, X Ju, S Zhao, Z Li, M Su, J Xu, P Wang… - Mbio, 2022 - Am Soc Microbiol
Ubiquitin signaling is essential for immunity to restrict pathogen proliferation. Due to its
enormous impact on human health and the global economy, intensive efforts have been …